Patent Assignment
Reel/Frame 059438/0355
Assignment of Assignor's Interest
Recorded: 2022-03-30
Pages: 3
Assignors
PORADOSU, ENRIQUE
Executed: 2014-02-03
OLIVIERO III, JAMES F.
Executed: 2014-02-03
BENTSUR, RON
Executed: 2014-02-03
Assignee
KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE, 20TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(2)
Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients
Application:
15/895,469 →
Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients
Application:
16/154,268 →
Publication:
US 2019/0269645
Related Assignments
(14)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Nov 26, 2019
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 051119/0089 →
Security Interest
Apr 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 052295/0662 →
Second Amended and Restated Intellectual Property Security Agreement
Sep 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 053671/0221 →
Third Amended and Restated Intellectual Property Security Agreement
Sep 10, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054173/0451 →
Fourth Amended and Restated Intellectual Property Security Agreement
Dec 17, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054793/0455 →
Fifth Amended and Restated Intellectual Property Security Agreement
Mar 30, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 055776/0491 →
Sixth Amended and Restated Intellectual Property Security Agreement
Jun 11, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 056544/0468 →
Seventh Amended and Restated Intellectual Property Security Agreement
Sep 12, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 057474/0770 →
Security Interest
Dec 15, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 058399/0055 →
Tenth Amended and Restated Intellectual Property Security Agreement
Jun 16, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 060529/0168 →
Eleventh Amended and Restated Intellectual Property Security Agreement
Aug 22, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 061297/0238 →
Twelfth Amended and Restated Intellectual Property Security Agreement
Nov 29, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 062012/0561 →
Termination and Release of Security Interest in Patents
Jan 29, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 066377/0741 →
Termination and Release of Security Interest in Patents
Jun 25, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 067839/0134 →